carbazilquinone has been researched along with Carcinoma, Bronchogenic in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, S | 1 |
| Hayashi, K | 1 |
| Ree, T | 1 |
| Saotome, K | 1 |
| Yanai, N | 1 |
| Iriki, A | 1 |
| Kimura, S | 1 |
| Hirata, M | 1 |
| Nishiyama, Y | 1 |
| Kawamura, M | 1 |
1 other study available for carbazilquinone and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
[Long-term results of the pulmonary resection with and without combined antineoplastic agents for primary bronchogenic carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carbazilquinone; Carcinoma, Bron | 1985 |